301333.SZ
R&G PharmaStudies Co., Ltd.
SZSE · M 科研服务 · CN
CNY 56.44
+8.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 39.82x
- PEG TTM
- 33.16x
- Price / book
- 2.73x
- Price / sales
- 5.97x
- Price / cash flow
- 49.84x
Enterprise value
- Enterprise value
- CNY 4.2B
- EV / sales
- 4.71x
- EV / EBITDA
- 23.55x
- EV / EBIT
- 27.73x
- Market cap
- CNY 5.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026